Table 3.
Studies assessing the association between cytokine levels in HM and FA in infants.
Study | Number of subjects | Duration of followup | Cytokines assessed | FA |
---|---|---|---|---|
Saarinen 1999 91, Finland | 6209 | 12 months | TGFβ-1, TGFβ-2 | Higher TGFβ-1 levels in colostrum are associated with infants who develop IgE-mediated cow’s milk allergy versus non-IgE-mediated cow’s milk allergy; healthy controls were found in between |
Bottcher 2003 92, Sweden | 53 | 2 years | IL-4, IL-5, IL-6, IL-8, IL-10, IL-13, IL-16, IFN-γ, TGFβ-1, TGFβ-2, RANTES, eotaxin | No significant association |
Snijders 2006 93, Netherlands | 315 | 2 years | IL-12 or TGFβ-1 (IL-10 undetectable) | No significant association |
Kuitunen 2012 94, Finland | 364 (colostrum) 321 (BM) | 2 years | IL-10, TGFβ-1 | No significant association |
Järvinen 2015 88, Finland | 145 | 2 years | IL-1α, IL-1β, IL-6,
IL-10 PDGF-BB, CCL27, VEGF, TSLP, CCL11, CXCL10, and CXCL11, CCL22, TGFβ-1, TNF-a and -b, CCL1, CCL17, IL-31, eotaxin 3, CXCL9, IL-5, GM-CSF, and IL-12p70 |
Higher levels of IL-1β, IL-6, IL-10, and TGFβ-1 in HM showed association with cow’s milk tolerance |
Munblit 2017 95, United Kingdom, Russia and Italy | 398 | 6 months | IL-2, IL-4, IL-5, IL-10, IFNγ, IL-12, IL-13, HGF, TGFβ-1, TGFβ-2, TGFβ-3 | Higher IL-13 levels associated with protection, otherwise no significant association |
Berdi 2018 96, France | 263 | 5 years | Eotaxin, CX3CL1, CXCL1, IL-8, CXCL10, CCL7, CCL22, CCL2, CCL3, CCL4, RANTES, IFNα2, IFNγ, IL-10, IL-12p40, IL-12p70, IL-15, IL-17A, IL-1RA, IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IL-13, sCD40L, TNFα, TNFβ, EGF, FGF-2, G-CSF, Flt3L, GM-CSF, PDGF-AA, PDGF-BB, TGFα, VEGF | Higher levels of CXCL10, TNFβ and IL-2 associated with protection against FA |